LATAM’s growing role in early-phase trials

You're not just running trials—you’re racing timelines, navigating regulations, and chasing precision. This edition gives you the strategic edge to move faster, launch smarter, and avoid costly setbacks across emerging and established markets.

MedTech

You're not just running trials—you’re racing timelines, navigating regulations, and chasing precision. This edition gives you the strategic edge to move faster, launch smarter, and avoid costly setbacks across emerging and established markets.

Recalibrate your LATAM strategy with Brazil’s new 2027 roadmap Unlock faster approvals by leveraging Australia’s TGA pathways Adjust your Medtech plans to stay ahead of MDR reforms in the EU Learn from a biotech that secured IND and Fast Track success

Let’s go 👇

← All Global Trial Accelerators editions · Contact bioaccess®